Bunnage Mark E.
Vertex Pharmaceuticals Inc · EVP
Bunnage Mark E. is listed in filings as EVP at Vertex Pharmaceuticals Inc. This profile follows SEC Form 4 activity through May 19, 2026, including sale activity. Recent filings connect the profile to Vertex Pharmaceuticals Inc (VRTX). The current snapshot covers public activity from Feb 12, 2026 to May 19, 2026. Reported amounts are shown as $15.0K to $282.3K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $15k33 shares | SellMay 15, 2026 | $453.45 | $481.00 |